Answers are grounded in this paper and cite their sources.
< .01). Race and ethnicity remain underreported in dermatologic clinical trials, and US trial participant diversity differs by skin disease, intervention type, and trial phase.
No takes yet. Share an insight, caveat, or question.
Sevagamoorthy et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: